Inhibitors | Comment | Organism | Structure |
---|---|---|---|
(3E)-4-[4-[(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]phenyl]but-3-enoic acid | comparison with inhibition of Mycobacterium tuberculosis enzyme | Homo sapiens | |
(3E)-4-[4-[(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]phenyl]but-3-enoic acid | comparison with inhibition of human enzyme | Mycobacterium tuberculosis | |
1-(4-bromobenzyl)-5-methylpyrimidine-2,4(1H,3H)-dione | comparison with inhibition of human enzyme | Mycobacterium tuberculosis | |
4-[4-[(5-bromo-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]phenyl]butanamide | not inhibitory up to 2 mM, inhibitory to Mycobacterium tuberculosis enzyme | Homo sapiens | |
4-[4-[(5-bromo-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]phenyl]butanamide | comparison with inhibition of human enzyme | Mycobacterium tuberculosis | |
4-[4-[(5-bromo-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]phenyl]butanoic acid | comparison with inhibition of Mycobacterium tuberculosis enzyme | Homo sapiens | |
4-[4-[(5-bromo-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]phenyl]butanoic acid | comparison with inhibition of human enzyme | Mycobacterium tuberculosis | |
4-[4-[(5-chloro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]phenyl]butanamide | not inhibitory up to 2 mM, inhibitory to Mycobacterium tuberculosis enzyme | Homo sapiens | |
4-[4-[(5-chloro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]phenyl]butanamide | comparison with inhibition of human enzyme | Mycobacterium tuberculosis | |
4-[4-[(5-chloro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]phenyl]butanoic acid | comparison with inhibition of Mycobacterium tuberculosis enzyme | Homo sapiens | |
4-[4-[(5-chloro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]phenyl]butanoic acid | comparison with inhibition of human enzyme | Mycobacterium tuberculosis | |
4-[4-[(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]phenyl]butanoic acid | comparison with inhibition of human enzyme | Mycobacterium tuberculosis | |
5-[4-[(5-bromo-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]phenyl]pentanoic acid | comparison with inhibition of human enzyme | Mycobacterium tuberculosis | |
5-[4-[(5-chloro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]phenyl]pentanoic acid | comparison with inhibition of Mycobacterium tuberculosis enzyme | Homo sapiens | |
5-[4-[(5-chloro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]phenyl]pentanoic acid | comparison with inhibition of human enzyme | Mycobacterium tuberculosis | |
6-[4-[(5-bromo-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]phenyl]hexanamide | comparison with inhibition of human enzyme | Mycobacterium tuberculosis | |
6-[4-[(5-chloro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]phenyl]hexanamide | comparison with inhibition of human enzyme | Mycobacterium tuberculosis | |
6-[4-[(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]phenyl]hexanamide | comparison with inhibition of human enzyme | Mycobacterium tuberculosis |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Mycobacterium tuberculosis | - |
- |
- |
Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|
0.0065 | - |
4-[4-[(5-chloro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]phenyl]butanoic acid | - |
Mycobacterium tuberculosis | |
0.01 | - |
4-[4-[(5-bromo-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]phenyl]butanoic acid | - |
Mycobacterium tuberculosis | |
0.013 | - |
4-[4-[(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]phenyl]butanoic acid | - |
Mycobacterium tuberculosis | |
0.016 | - |
5-[4-[(5-chloro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]phenyl]pentanoic acid | - |
Mycobacterium tuberculosis | |
0.0195 | - |
6-[4-[(5-bromo-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]phenyl]hexanamide | - |
Mycobacterium tuberculosis | |
0.026 | - |
6-[4-[(5-chloro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]phenyl]hexanamide | - |
Mycobacterium tuberculosis | |
0.0265 | - |
6-[4-[(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]phenyl]hexanamide | - |
Mycobacterium tuberculosis | |
0.038 | - |
1-(4-bromobenzyl)-5-methylpyrimidine-2,4(1H,3H)-dione | - |
Mycobacterium tuberculosis | |
0.038 | - |
5-[4-[(5-bromo-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]phenyl]pentanoic acid | - |
Mycobacterium tuberculosis | |
0.039 | - |
(3E)-4-[4-[(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]phenyl]but-3-enoic acid | - |
Mycobacterium tuberculosis | |
0.039 | - |
4-[4-[(5-bromo-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]phenyl]butanamide | - |
Mycobacterium tuberculosis | |
0.039 | - |
4-[4-[(5-chloro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]phenyl]butanamide | - |
Mycobacterium tuberculosis | |
0.122 | - |
5-[4-[(5-chloro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]phenyl]pentanoic acid | - |
Homo sapiens | |
0.252 | - |
(3E)-4-[4-[(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]phenyl]but-3-enoic acid | - |
Homo sapiens | |
0.293 | - |
4-[4-[(5-bromo-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]phenyl]butanoic acid | - |
Homo sapiens | |
0.79 | - |
4-[4-[(5-chloro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]phenyl]butanoic acid | - |
Homo sapiens |